Immunomodulatory Potential of Apium graveolens: Emerging Pharmacological Perspectives

Abstract

Apium graveolens has become a promising phytotherapeutic agent with multiple pharmacological applications; but its immunomodulatory effects have not been well studied in a mechanistic approach. This is a thorough and integrative review of the immunomodulatory properties of Apium graveolens, focusing on its bioactive compounds, molecular targets, and translational significance. Apigenin, luteolin, and phthalides are the important phytochemicals that have pleiotropic actions because they regulate the key immune pathways, nuclear factor-kappa B (NF-KB) signaling, cytokine interactions, and oxidative stress-mediated immune responses. All of these compounds affect the innate and adaptive immunity by modulating the macrophage activation, T-cell responses, and the inflammatory mediators. Notably, this review suggests a single mechanistic model whereby Apium graveolens acts as a multitarget immunomodulator by integrating the NF- kBcytokine axis with the oxidative stress-immune interface. Although there is strong preclinical evidence, there are still important gaps in clinical confirmation, dose standardisation and immune specific studies. This paper demonstrates the promise of Apium graveolens as a new candidate to develop into immunotherapeutics and emphasizes the necessity of sophisticated experimental and clinical research to transform its pharmacological potential into clinical use.